| Bioactivity | MERS-CoV-IN-1 exhibits excellent inhibitory activity against coronavirus. MERS-CoV-IN-1 is useful as a pharmaceutical composition for preventing coronavirus-induced diseases (MERS-CoV and SARS) (extracted from patent WO2018174442A1, compound 1)[1]. | ||||||||||||
| Target | MERS-CoV and SARS | ||||||||||||
| Name | MERS-CoV-IN-1 | ||||||||||||
| CAS | 2245697-92-9 | ||||||||||||
| Formula | C19H17NO2 | ||||||||||||
| Molar Mass | 291.34 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Compound for treating diseases caused by coronavirus infection. Patent WO2018174442A1. |
MERS-CoV-IN-1
CAS: 2245697-92-9 F: C19H17NO2 W: 291.34
MERS-CoV-IN-1 exhibits excellent inhibitory activity against coronavirus. MERS-CoV-IN-1 is useful as a pharmaceutical co
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.